Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $539.6 million.

  • Haemonetics' Accumulated Depreciation & Amortization fell 3835.18% to $539.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $539.6 million, marking a year-over-year decrease of 3835.18%. This contributed to the annual value of $553.1 million for FY2025, which is 1461.42% down from last year.
  • As of Q4 2025, Haemonetics' Accumulated Depreciation & Amortization stood at $539.6 million, which was down 3835.18% from $522.8 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Accumulated Depreciation & Amortization registered a high of $875.3 million during Q4 2024, and its lowest value of $508.2 million during Q2 2025.
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $635.8 million (2023), whereas its average is $622.6 million.
  • Per our database at Business Quant, Haemonetics' Accumulated Depreciation & Amortization surged by 3248.9% in 2024 and then crashed by 3835.18% in 2025.
  • Over the past 5 years, Haemonetics' Accumulated Depreciation & Amortization (Quarter) stood at $599.7 million in 2021, then rose by 1.83% to $610.7 million in 2022, then rose by 8.18% to $660.6 million in 2023, then soared by 32.49% to $875.3 million in 2024, then plummeted by 38.35% to $539.6 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $539.6 million for Q4 2025, versus $522.8 million for Q3 2025 and $508.2 million for Q2 2025.